Neuroendocrine Tumor Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
ABUS | B | Arbutus Biopharma Corporation | 0.96 | |
CRNX | D | Crinetics Pharmaceuticals, Inc. | -2.94 | |
AQST | F | Aquestive Therapeutics, Inc. | -0.41 |
Related Industries: Biotechnology
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SBIO | D | ALPS Medical Breakthroughs ETF | 2.59 | |
PTH | C | Invesco DWA Healthcare Momentum ETF | 1.82 | |
BBC | D | Virtus LifeSci Biotech Clinical Trials ETF | 1.73 | |
GERM | D | ETFMG Treatments Testing and Advancements ETF | 1.38 | |
MMSC | B | First Trust Multi-Manager Small | 1.13 |
Compare ETFs
Date | Stock | Title |
---|---|---|
Jun 27 | AQST | Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism |
Related Industries:
Biotechnology
- Neuroendocrine Tumor
A neuroendocrine tumor (NET) is a type of cancer that develops from cells of the neuroendocrine system. This system is made up of cells that release hormones in response to signals from the nervous system. Neuroendocrine tumors can occur anywhere in the body and can be benign (non-cancerous) or malignant (cancerous). Symptoms of NETs vary depending on the location and type of tumor, but may include abdominal pain, diarrhea, weight loss, and fatigue. Treatment options may include surgery, chemotherapy, radiation, and targeted therapy.
Recent Comments
- TraderMike on Bollinger Band Squeeze
- TraderMike on Bollinger Band Squeeze
- OpenCat584 on Bollinger Band Squeeze
- Dr_Duru on Expansion Breakout
- TraderMike on New Scans: Strong, Oversold Stocks and Weak, Overbought Stocks
From the Blog
Featured Articles